Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Mol Cancer Ther. 2018 Feb 13;17(5):1061–1069. doi: 10.1158/1535-7163.MCT-17-0925

Figure 1. Expression levels and clinical significance of miR-203 and HOTAIR in renal cancer.

Figure 1

(A) and (C) Expression levels of miR-203 and HOTAIR, respectively in ACHN, Caki-1 and HK2. (B) and (D) Expression levels of miR-203 and HOTAIR in tissue samples (n=24). (E and F) Receiver operating curve (ROC) analysis showing ability of miR-203 and HOTAIR to distinguish between malignant and non-malignant tissue samples. (G and H) Chi-square test showing correlation of clinicopathological variables with miR-203 and HOTAIR expression.